NCT00003080View on ClinicalTrials.gov

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 1996

Primary Completion Date

May 31, 2001

Study Completion Date

May 31, 2001

Conditions
Ovarian Cancer
Interventions
DRUG

endocrine-modulating drug therapy

DRUG

melphalan

DRUG

mitoxantrone hydrochloride

DRUG

tamoxifen citrate

DRUG

thiotepa

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (1)

98109

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00003080 - Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer | Biotech Hunter | Biotech Hunter